CYduct Diagnostics Inc (CYDX)

[parker4]

Solos Endoscopy Reports Financial Results for Period Ended June 30, 2014
Accesswire
15 minutes ago
BOSTON, MA / ACCESSWIRE / August 18, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (SNDY) a provider of quality innovative healthcare instruments to Hospitals across the United States, reported sales and earnings results for period ended June 30, 2014, and its quarterly disclosure statement on OTC Markets.com.

The Company posted the results on the OTC Markets website (http://www.otcmarkets.com/stock/SNDY/filings)

Solos Endoscopy completed the Audit with TUV SUD America this past year, which included a comprehensive review of the Solos Endoscopy's Quality Manual and 28 Quality System Procedures for compliance with the international quality system standard ISO 13485:2003, to the European Union's Medical Device Directive (MDD 93/42/EEC) and to the Canadian Medical Device Regulations (SOR/98-282). Since the completion of the initial audit, the Company has been in contact with the representatives from both TUV SUD and Expert Resources and expects to conduct its annual audit to maintain its ISO 13485:2003 standing, in the next few weeks. Certification to ISO 13485:2003 will in turn allow Solos Endoscopy to obtain the CE Mark on the majority of endoscopic instruments including the MammoView(r) devices.

Solos is developing new products that will enhance the way minimally invasive surgical procedures are utilized in hospitals. These products will allow the physician to operate on an individual's organs and tissues within the body without the need for intrusive surgery. The Company is currently marketing its next generation breast endoscopy system, the MammoView(r) system, for early breast cancer detection.